Utility of CT radiomics for prediction of PD-L1 expression in advanced lung adenocarcinomas

被引:69
|
作者
Yoon, Jiyoung [1 ]
Suh, Young Joo [1 ]
Han, Kyunghwa [1 ]
Cho, Hyoun [1 ]
Lee, Hye-Jeong [1 ]
Hur, Jin [1 ]
Choi, Byoung Wook [1 ]
机构
[1] Yonsei Univ, Severance Hosp, Coll Med, Res Inst Radiol Sci,Dept Radiol, Seoul, South Korea
关键词
Computed tomography; immunotherapy; lung adenocarcinoma; programmed death ligand 1; radiomics; FACTOR RECEPTOR MUTATION; DEATH LIGAND 1; EGFR MUTATION; INTERNATIONAL ASSOCIATION; COMPUTED-TOMOGRAPHY; TEXTURE ANALYSIS; STAGE-I; CANCER; CLASSIFICATION; FEATURES;
D O I
10.1111/1759-7714.13352
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background We aimed to assess if quantitative radiomic features can predict programmed death ligand 1 (PD-L1) expression in advanced stage lung adenocarcinoma. Methods This retrospective study included 153 patients who had advanced stage (>IIIA by TNM classification) lung adenocarcinoma with pretreatment thin section computed tomography (CT) images and PD-L1 expression test results in their pathology reports. Clinicopathological data were collected from electronic medical records. Visual analysis and radiomic feature extraction of the tumor from pretreatment CT were performed. We constructed two models for multivariate logistic regression analysis (one based on clinical variables, and the other based on a combination of clinical variables and radiomic features), and compared c-statistics of the receiver operating characteristic curves of each model to identify the model with the higher predictability. Results Among 153 patients, 53 patients were classified as PD-L1 positive and 100 patients as PD-L1 negative. There was no significant difference in clinical characteristics or imaging findings on visual analysis between the two groups (P > 0.05 for all). Rad-score by radiomic analysis was higher in the PD-L1 positive group than in the PD-L1 negative group with a statistical significance (-0.378 +/- 1.537 vs. -1.171 +/- 0.822, P = 0.0008). A prediction model that uses clinical variables and CT radiomic features showed higher performance compared to a prediction model that uses clinical variables only (c-statistic = 0.646 vs. 0.550, P = 0.0299). Conclusions Quantitative CT radiomic features can predict PD-L1 expression in advanced stage lung adenocarcinoma. A prediction model composed of clinical variables and CT radiomic features may facilitate noninvasive assessment of PD-L1 expression. Key points Significant findings of the study Quantitative CT radiomic features can help predict PD-L1 expression, whereas none of the qualitative imaging findings is associated with PD-L1 positivity. What this study adds A prediction model composed of clinical variables and CT radiomic features may facilitate noninvasive assessment of PD-L1 expression.
引用
收藏
页码:993 / 1004
页数:12
相关论文
共 50 条
  • [31] CT-based radiomics for differentiating invasive adenocarcinomas from indolent lung adenocarcinomas appearing as ground-glass nodules: A systematic review
    Shi, Lili
    Zhao, Jinli
    Peng, Xueqing
    Wang, Yunpeng
    Liu, Lei
    Sheng, Meihong
    EUROPEAN JOURNAL OF RADIOLOGY, 2021, 144
  • [32] Tumor necrosis correlates with PD-L1 and PD-1 expression in lung adenocarcinoma
    Reiniger, Lilla
    Teglasi, Vanda
    Pipek, Orsolya
    Rojko, Livia
    Glasz, Tibor
    Vagvoelgyi, Attila
    Kovalszky, Ilona
    Gyulai, Marton
    Lohinai, Zoltan
    Raso, Erzsebet
    Timar, Jozsef
    Dome, Balazs
    Szallasi, Zoltan
    Moldvay, Judit
    ACTA ONCOLOGICA, 2019, 58 (08) : 1087 - 1094
  • [33] The utility of quantitative CT radiomics features for improved prediction of radiation pneumonitis
    Krafft, Shane P.
    Rao, Arvind
    Stingo, Francesco
    Briere, Tina Marie
    Court, Laurence E.
    Liao, Zhongxing
    Martel, Mary K.
    MEDICAL PHYSICS, 2018, 45 (11) : 5317 - 5324
  • [34] PD-1 and PD-L1 expression in rare lung tumors
    Gyulai, Marton
    Megyesfalvi, Zsolt
    Reiniger, Lilla
    Harko, Tunde
    Ferencz, Bence
    Karsko, Luca
    Agocs, Laszlo
    Fillinger, Janos
    Dome, Balazs
    Szallasi, Zoltan
    Moldvay, Judit
    PATHOLOGY & ONCOLOGY RESEARCH, 2023, 29
  • [35] Deep learning radiomics model based on PET/CT predicts PD-L1 expression in non-small cell lung cancer
    Li, Bo
    Su, Jie
    Liu, Kai
    Hu, Chunfeng
    EUROPEAN JOURNAL OF RADIOLOGY OPEN, 2024, 12
  • [36] Radiomics Study for Predicting the Expression of PD-L1 and Tumor Mutation Burden in Non-Small Cell Lung Cancer Based on CT Images and Clinicopathological Features
    Wen, Qiang
    Yang, Zhe
    Dai, Honghai
    Feng, Alei
    Li, Qiang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [37] PD-L1 Copy Number Variation Does Not Correlate With PD-L1 Expression or Response to Anti-PD-1 Immunotherapy In Patients With Advanced Melanomas
    Perottet, Jeremy
    Le Goff, Emeline
    Legoupil, Delphine
    Quere, Gilles
    Schick, Ulrike
    Marcorelles, Pascale
    Uguen, Arnaud
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (02) : 161 - 165
  • [38] Self-supervised contrastive learning using CT images for PD-1/PD-L1 expression prediction in hepatocellular carcinoma
    Xie, Tianshu
    Wei, Yi
    Xu, Lifeng
    Li, Qian
    Che, Feng
    Xu, Qing
    Cheng, Xuan
    Liu, Minghui
    Yang, Meiyi
    Wang, Xiaomin
    Zhang, Feng
    Song, Bin
    Liu, Ming
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [39] Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma
    Koh, Young wha
    Han, Jae-ho
    Haam, Seokjin
    Lee, Hyun woo
    ANTICANCER RESEARCH, 2024, 44 (05) : 2081 - 2089
  • [40] Correlation of CT parameters and PD-L1 expression status in gastric cancer
    Xu, Min
    Ren, Tiezhu
    Deng, Juan
    Yang, Jingjing
    Lu, Ting
    Xi, Huaze
    Yuan, Long
    Zhang, Wenjuan
    Zhou, Junlin
    ABDOMINAL RADIOLOGY, 2024, 49 (4) : 1320 - 1329